Fros, I wouldn't bullshit you. The first time we learned how TD2 got involved was back in 2014 in this radio interview with Ken Waggoner and Dr Crabtree. Ken told us that Dr Von Hoff contacted him via email. And it was Dr Von Hoff who wanted to do trials with Cell in a Box for pain and malignant ascites. "It was never our idea", he said... Listen circa 10:10 in this radio interview. http://www.stockmarketmediagroup.com/wp-content/uploads/2014/06/NVLX-CEO-COO-Interview.mp3
Like you, many refused to believe what our CEO said so when we did the corporate interview recently, we learned the same thing. The president and CEO of TD2, Stephen Gately told us that actually Dr Von Hoff saw the data and reached out to KW.